Evidence map›Paper›PMID 34135341›Full record

ArticleNature communications2021

Extracellular mRNA transported to the nucleus exerts translation-independent function.

Takeshi Tomita, Masayoshi Kato, Taishi Mishima, Yuta Matsunaga, Hideki Sanjo, Ken-Ichi Ito, Kentaro Minagawa, Toshimitsu Matsui, Hiroyuki Oikawa, Satoshi Takahashi and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Condensates on the Move: Midbody Remnants as Large, Translation-Competent Extracellular Vesicles.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. Article
  3. Synthetic short RNA in cancer.Frontiers in oncology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. ZC3H12D upregulation in head and neck squamous cell carcinoma: a potential prognostic biomarker associated with immune infiltration.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Takeshi TomitaInstitute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, School of Medicine, Matsumoto, Nagano, Japan.ORCID 0000-0001-6815-2244
Masayoshi KatoInstitute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, School of Medicine, Matsumoto, Nagano, Japan.ORCID 0000-0003-2170-3373
Taishi MishimaDepartment of Pharmacology, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan.
Yuta MatsunagaDepartment of Pharmacology, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan.
Hideki SanjoDepartment of Molecular and Cellular Immunology, Shinshu University, School of Medicine, Matsumoto, Nagano, Japan.
Ken-Ichi ItoDivision of Breast, Endocrine and Respiratory Surgery, Department of Surgery, Shinshu University, School of Medicine, Matsumoto, Nagano, Japan.
Kentaro MinagawaDepartment of Hematology/Oncology, Penn State College of Medicine, Hershey, PA, USA.
Toshimitsu MatsuiDepartment of Hematology, Nishiwaki Municipal Hospital, Nishiwaki, Hyogo, Japan.ORCID 0000-0002-2536-7584
Hiroyuki OikawaInstitute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai, Japan.ORCID 0000-0001-5216-0813
Satoshi TakahashiInstitute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai, Japan.
Toshifumi TakaoInstitute for Protein Research, Osaka University, Suita, Osaka, Japan.
Noriki IwaiDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takashi MinoDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-9562-008X
Osamu TakeuchiDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-1260-6232
Yoshiro MaruDepartment of Pharmacology, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan. maru.yoshiro@twmu.ac.jp.ORCID 0000-0002-9477-7974
Sachie HiratsukaInstitute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, School of Medicine, Matsumoto, Nagano, Japan. hira@shinshu-u.ac.jp.ORCID 0000-0002-6507-7362
Shinshu University · JPKyoto University · JPTokyo Women's Medical University · JPTohoku University · JPKashiwa Municipal Hospital · JPPenn State Milton S. Hershey Medical Center · USProtein Research Foundation · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA in extracellular vesicles (EVs) are uptaken by cells, where they regulate fundamental cellular functions. EV-derived mRNA in recipient cells can be translated. However, it is still elusive whether "naked nonvesicular extracellular mRNA" (nex-mRNA) that are not packed in EVs can be uptaken by cells and, if so, whether they have any functions in recipient cells. Here, we show the entrance of nex-mRNA in the nucleus, where they exert a translation-independent function. Human nex-interleukin-1β (IL1β)-mRNA outside cells proved to be captured by RNA-binding zinc finger CCCH domain containing protein 12D (ZC3H12D)-expressing human natural killer (NK) cells. ZC3H12D recruited to the cell membrane binds to the 3'-untranslated region of nex-IL1β-mRNA and transports it to the nucleus. The nex-IL1β-mRNA in the NK cell nucleus upregulates antiapoptotic gene expression, migration activity, and interferon-γ production, leading to the killing of cancer cells and antimetastasis in mice. These results implicate the diverse actions of mRNA.

Indexed as

3' Untranslated RegionsAnimalsAntineoplastic AgentsCell Cycle ProteinsCell Line, TumorCell MembraneCell NucleusCulture Media, ConditionedEndoribonucleasesExtracellular SpaceHumansInterleukin-1betaKiller Cells, NaturalMiceProtein BindingRNA-Binding Proteins3' Untranslated RegionsAntineoplastic AgentsCell Cycle ProteinsCulture Media, ConditionedEndoribonucleasesIL1B protein, humanInterleukin-1betaRNA-Binding ProteinsRNA, MessengerZC3H12D protein, human

Identifiers

PMID34135341
PMCPMC8208975
OpenAlexW3172853488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.